Fueling Transformative Healthcare Companies With Investment in Invention.
We fund exceptional teams developing compelling, well-protected innovations that will significantly impact the healthcare system.
Strategy & Approach
Grey Sky Venture Partners focuses on discovering and funding exceptional management teams developing compelling, well-protected innovations springing from leading-edge research that have the potential to significantly impact the complex and rapidly changing healthcare system.
We make early-stage investments in healthcare and medical technology companies that seek to improve clinical outcomes, enhance quality of life, or reduce system costs. With a heritage rooted in invention, Grey Sky also brings intellectual property expertise and access to a patent portfolio that can be strategically valuable to young companies.
Grey Sky identifies new early-stage investment opportunities by tapping into a broad network of industry relationships and through screened thematic research into emergent diagnostic and therapeutic areas in healthcare. Following our initial investment, we work closely with portfolio companies and syndicate partners to develop and implement strategic plans, achieve operating objectives, build great teams, raise additional capital, and pursue liquidity opportunities in a manner that optimizes returns to all stakeholders.
Our company name was inspired by the frequently cloudy skies of the verdant Pacific Northwest, a region to which the fund has important ties.
Founder & Partner
Michael is a Founder and Partner at Grey Sky Venture Partners. Prior to Grey Sky, Michael helped launch two of the top strategic venture firms in the world (Intel Capital and Steamboat Ventures), two successful private venture capital funds (Palisades Ventures and DE Shaw Ventures) and seed capital fund Windy Hill Capital.
At Intel Capital, Michael managed a team of 20 professionals investing in advanced technologies for the Architecture Labs and New Business Group. At Disney’s Steamboat Ventures and at Palisades Ventures, Michael was a partner leading investments in a variety of digital technology categories.
In 2007, Michael joined DE Shaw Ventures to run media investments, and in 2012, Michael launched Windy Hill Capital, a seed fund focused on investments in advanced HW and SW technologies. Prior to venture capital, Michael was an entrepreneur and consultant.
Michael earned his MA and BA from Stanford University and his MBA from The Anderson School.
Paul is a Partner at Grey Sky Venture Partners. His diverse background has spanned across the biomedical and technology sectors as an inventor, entrepreneur, business development professional, and venture investor. Previously, he worked at the Invention Science Fund, a leading invention and intellectual property investment company.
While there, he worked at the intersection of healthcare and technology innovation and was responsible for in-depth market analyses and strategic business development.
Earlier in his career, Paul was a member of the Strategic Business Unit at KLA-Tencor where he managed B2B relationships, product development and global launches at key customer sites such as Intel Corporation and TSMC.
Paul holds an MBA from the MIT Sloan School of Management and a PhD in Biomedical Engineering from Northwestern University.
Founder & Partner
Todd is a Founder and Partner at Grey Sky Venture Partners. Prior to Grey Sky, he was Vice President of Business Development at the Invention Science Fund, a leading invention and intellectual property investment company. His responsibilities included overseeing the incubation of new spinout companies, where played a key role in the formation and venture funding of several startups.
He was also an executive at Microvision, Inc., a pioneer in optical beam-scanning display and imaging systems, where he led corporate development as the company progressed from bench-stage technology to product introduction. While there he also founded Lumera Corporation, a developer of optical communications and biomedical analysis devices based on proprietary nanomaterials. He served in a senior leadership capacity as both businesses grew to become successful publicly listed companies.
Todd holds an MBA from Stanford University and a BA from Hendrix College.